nodes	percent_of_prediction	percent_of_DWPC	metapath
Azacitidine—DNMT1—Cytosine methylation—IDH2—osteoporosis	0.0386	0.178	CbGpPWpGaD
Azacitidine—DNMT3A—One Carbon Metabolism—ATIC—osteoporosis	0.0327	0.151	CbGpPWpGaD
Azacitidine—DNMT1—One Carbon Metabolism—ATIC—osteoporosis	0.0221	0.102	CbGpPWpGaD
Azacitidine—CDA—Nucleotide metabolism—PNP—osteoporosis	0.0138	0.0638	CbGpPWpGaD
Azacitidine—CDA—Nucleotide metabolism—ATIC—osteoporosis	0.0138	0.0638	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—COL1A2—osteoporosis	0.00945	0.0437	CbGpPWpGaD
Azacitidine—Cladribine—PNP—osteoporosis	0.00941	0.763	CrCbGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—DKK1—osteoporosis	0.00891	0.0412	CbGpPWpGaD
Azacitidine—DNMT3A—One Carbon Metabolism—MTHFR—osteoporosis	0.00855	0.0395	CbGpPWpGaD
Azacitidine—DNMT3A—Trans-sulfuration and one carbon metabolism—MTHFR—osteoporosis	0.00769	0.0355	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.00719	0.0332	CbGpPWpGaD
Azacitidine—DNMT1—One Carbon Metabolism—MTHFR—osteoporosis	0.00578	0.0267	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—BGLAP—osteoporosis	0.00533	0.0246	CbGpPWpGaD
Azacitidine—DNMT1—Trans-sulfuration and one carbon metabolism—MTHFR—osteoporosis	0.00519	0.024	CbGpPWpGaD
Azacitidine—DNMT3A—Estradiol—Estropipate—osteoporosis	0.00505	0.298	CbGdCrCtD
Azacitidine—DNMT1—Fulvestrant—Estradiol—osteoporosis	0.00487	0.287	CbGdCrCtD
Azacitidine—CDA—Nucleotide metabolism—GPX1—osteoporosis	0.00391	0.0181	CbGpPWpGaD
Azacitidine—DNMT3A—Estradiol—Conjugated Estrogens—osteoporosis	0.00383	0.226	CbGdCrCtD
Azacitidine—DNMT3A—Estradiol—Ethinyl Estradiol—osteoporosis	0.00322	0.19	CbGdCrCtD
Azacitidine—Glucosamine—TNF—osteoporosis	0.00293	0.237	CrCbGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—MYC—osteoporosis	0.00207	0.00955	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—U2AF1—osteoporosis	0.00168	0.00778	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PKM—osteoporosis	0.00145	0.00669	CbGpPWpGaD
Azacitidine—CDA—Metabolism—FDPS—osteoporosis	0.00145	0.00669	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GPD2—osteoporosis	0.00137	0.00634	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PGLS—osteoporosis	0.00137	0.00634	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PNP—osteoporosis	0.00125	0.0058	CbGpPWpGaD
Azacitidine—CDA—Metabolism—ATIC—osteoporosis	0.00125	0.0058	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—RPL24—osteoporosis	0.00125	0.00578	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—U2AF1—osteoporosis	0.00114	0.00525	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.00108	0.00498	CbGpPWpGaD
Azacitidine—CDA—Metabolism—OXCT1—osteoporosis	0.00107	0.00493	CbGpPWpGaD
Azacitidine—CDA—Metabolism—CA2—osteoporosis	0.00107	0.00493	CbGpPWpGaD
Azacitidine—CDA—Metabolism—MGLL—osteoporosis	0.00104	0.0048	CbGpPWpGaD
Azacitidine—CDA—Metabolism—IDH2—osteoporosis	0.000884	0.00408	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—RPL24—osteoporosis	0.000845	0.0039	CbGpPWpGaD
Azacitidine—CDA—Metabolism—CYP27A1—osteoporosis	0.000831	0.00384	CbGpPWpGaD
Azacitidine—CDA—Metabolism—ACP5—osteoporosis	0.000809	0.00374	CbGpPWpGaD
Azacitidine—CDA—Metabolism—TPI1—osteoporosis	0.000752	0.00347	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—PSMA2—osteoporosis	0.000722	0.00334	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—PSMA5—osteoporosis	0.000722	0.00334	CbGpPWpGaD
Azacitidine—CDA—Metabolism—P4HB—osteoporosis	0.000707	0.00327	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GAPDH—osteoporosis	0.000694	0.00321	CbGpPWpGaD
Azacitidine—CDA—Metabolism—RAP1A—osteoporosis	0.000676	0.00312	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—ESR2—osteoporosis	0.000645	0.00298	CbGpPWpGaD
Azacitidine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000564	0.000748	CcSEcCtD
Azacitidine—Asthenia—Estropipate—osteoporosis	0.000562	0.000745	CcSEcCtD
Azacitidine—Anorexia—Pamidronate—osteoporosis	0.000561	0.000744	CcSEcCtD
Azacitidine—Arthralgia—Zoledronate—osteoporosis	0.000561	0.000744	CcSEcCtD
Azacitidine—Myalgia—Zoledronate—osteoporosis	0.000561	0.000744	CcSEcCtD
Azacitidine—Chest pain—Zoledronate—osteoporosis	0.000561	0.000744	CcSEcCtD
Azacitidine—Insomnia—Risedronate—osteoporosis	0.00056	0.000743	CcSEcCtD
Azacitidine—Anxiety—Zoledronate—osteoporosis	0.000559	0.000741	CcSEcCtD
Azacitidine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000558	0.000739	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000557	0.000739	CcSEcCtD
Azacitidine—Pruritus—Estropipate—osteoporosis	0.000554	0.000735	CcSEcCtD
Azacitidine—Discomfort—Zoledronate—osteoporosis	0.000554	0.000735	CcSEcCtD
Azacitidine—Asthenia—Alendronate—osteoporosis	0.000554	0.000734	CcSEcCtD
Azacitidine—Hypersensitivity—Ibandronate—osteoporosis	0.000554	0.000734	CcSEcCtD
Azacitidine—Cough—Conjugated Estrogens—osteoporosis	0.000554	0.000734	CcSEcCtD
Azacitidine—Dyspnoea—Risedronate—osteoporosis	0.000552	0.000732	CcSEcCtD
Azacitidine—Hypotension—Pamidronate—osteoporosis	0.00055	0.000729	CcSEcCtD
Azacitidine—Convulsion—Conjugated Estrogens—osteoporosis	0.00055	0.000729	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000548	0.000727	CcSEcCtD
Azacitidine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000548	0.000726	CcSEcCtD
Azacitidine—CDA—Metabolism—ENO1—osteoporosis	0.000546	0.00252	CbGpPWpGaD
Azacitidine—Pruritus—Alendronate—osteoporosis	0.000546	0.000724	CcSEcCtD
Azacitidine—Dyspepsia—Risedronate—osteoporosis	0.000545	0.000723	CcSEcCtD
Azacitidine—Eye disorder—Estradiol—osteoporosis	0.000545	0.000723	CcSEcCtD
Azacitidine—Constipation—Ethinyl Estradiol—osteoporosis	0.000543	0.00072	CcSEcCtD
Azacitidine—Confusional state—Zoledronate—osteoporosis	0.000542	0.000719	CcSEcCtD
Azacitidine—Hypersensitivity—Calcitriol—osteoporosis	0.000542	0.000719	CcSEcCtD
Azacitidine—Cardiac disorder—Estradiol—osteoporosis	0.000541	0.000718	CcSEcCtD
Azacitidine—Myalgia—Conjugated Estrogens—osteoporosis	0.00054	0.000716	CcSEcCtD
Azacitidine—Chest pain—Conjugated Estrogens—osteoporosis	0.00054	0.000716	CcSEcCtD
Azacitidine—Arthralgia—Conjugated Estrogens—osteoporosis	0.00054	0.000716	CcSEcCtD
Azacitidine—Asthenia—Ibandronate—osteoporosis	0.000539	0.000715	CcSEcCtD
Azacitidine—CDA—Metabolism—PSMA5—osteoporosis	0.000538	0.00249	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PSMA2—osteoporosis	0.000538	0.00249	CbGpPWpGaD
Azacitidine—Anxiety—Conjugated Estrogens—osteoporosis	0.000538	0.000714	CcSEcCtD
Azacitidine—Nausea—Etidronic acid—osteoporosis	0.000538	0.000713	CcSEcCtD
Azacitidine—Anaphylactic shock—Zoledronate—osteoporosis	0.000538	0.000713	CcSEcCtD
Azacitidine—Oedema—Zoledronate—osteoporosis	0.000538	0.000713	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000536	0.000711	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000536	0.000711	CcSEcCtD
Azacitidine—Diarrhoea—Estropipate—osteoporosis	0.000536	0.000711	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000535	0.000709	CcSEcCtD
Azacitidine—Infection—Zoledronate—osteoporosis	0.000534	0.000708	CcSEcCtD
Azacitidine—Fatigue—Risedronate—osteoporosis	0.000534	0.000708	CcSEcCtD
Azacitidine—Insomnia—Pamidronate—osteoporosis	0.000532	0.000706	CcSEcCtD
Azacitidine—Pruritus—Ibandronate—osteoporosis	0.000532	0.000705	CcSEcCtD
Azacitidine—Pain—Risedronate—osteoporosis	0.00053	0.000702	CcSEcCtD
Azacitidine—Constipation—Risedronate—osteoporosis	0.00053	0.000702	CcSEcCtD
Azacitidine—Angiopathy—Estradiol—osteoporosis	0.000529	0.000702	CcSEcCtD
Azacitidine—Shock—Zoledronate—osteoporosis	0.000529	0.000701	CcSEcCtD
Azacitidine—Diarrhoea—Alendronate—osteoporosis	0.000528	0.0007	CcSEcCtD
Azacitidine—Asthenia—Calcitriol—osteoporosis	0.000528	0.0007	CcSEcCtD
Azacitidine—Nervous system disorder—Zoledronate—osteoporosis	0.000527	0.000699	CcSEcCtD
Azacitidine—Immune system disorder—Estradiol—osteoporosis	0.000527	0.000699	CcSEcCtD
Azacitidine—Thrombocytopenia—Zoledronate—osteoporosis	0.000526	0.000698	CcSEcCtD
Azacitidine—Mediastinal disorder—Estradiol—osteoporosis	0.000526	0.000697	CcSEcCtD
Azacitidine—Dyspnoea—Pamidronate—osteoporosis	0.000525	0.000696	CcSEcCtD
Azacitidine—Tachycardia—Zoledronate—osteoporosis	0.000525	0.000696	CcSEcCtD
Azacitidine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000523	0.000694	CcSEcCtD
Azacitidine—Chills—Estradiol—osteoporosis	0.000523	0.000694	CcSEcCtD
Azacitidine—Skin disorder—Zoledronate—osteoporosis	0.000522	0.000693	CcSEcCtD
Azacitidine—Pruritus—Calcitriol—osteoporosis	0.00052	0.00069	CcSEcCtD
Azacitidine—Hyperhidrosis—Zoledronate—osteoporosis	0.00052	0.000689	CcSEcCtD
Azacitidine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000519	0.000689	CcSEcCtD
Azacitidine—Diarrhoea—Raloxifene—osteoporosis	0.000519	0.000689	CcSEcCtD
Azacitidine—Dyspepsia—Pamidronate—osteoporosis	0.000518	0.000687	CcSEcCtD
Azacitidine—Dizziness—Estropipate—osteoporosis	0.000518	0.000687	CcSEcCtD
Azacitidine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000518	0.000687	CcSEcCtD
Azacitidine—Oedema—Conjugated Estrogens—osteoporosis	0.000518	0.000687	CcSEcCtD
Azacitidine—Alopecia—Estradiol—osteoporosis	0.000515	0.000683	CcSEcCtD
Azacitidine—Infection—Conjugated Estrogens—osteoporosis	0.000514	0.000682	CcSEcCtD
Azacitidine—Diarrhoea—Ibandronate—osteoporosis	0.000514	0.000682	CcSEcCtD
Azacitidine—Anorexia—Zoledronate—osteoporosis	0.000513	0.00068	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—VDR—osteoporosis	0.000512	0.00237	CbGpPWpGaD
Azacitidine—Decreased appetite—Pamidronate—osteoporosis	0.000512	0.000679	CcSEcCtD
Azacitidine—Mental disorder—Estradiol—osteoporosis	0.000511	0.000678	CcSEcCtD
Azacitidine—Dizziness—Alendronate—osteoporosis	0.00051	0.000677	CcSEcCtD
Azacitidine—Shock—Conjugated Estrogens—osteoporosis	0.000509	0.000675	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000508	0.000674	CcSEcCtD
Azacitidine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000508	0.000673	CcSEcCtD
Azacitidine—Erythema—Estradiol—osteoporosis	0.000508	0.000673	CcSEcCtD
Azacitidine—Malnutrition—Estradiol—osteoporosis	0.000508	0.000673	CcSEcCtD
Azacitidine—Fatigue—Pamidronate—osteoporosis	0.000508	0.000673	CcSEcCtD
Azacitidine—Gastrointestinal pain—Risedronate—osteoporosis	0.000506	0.000671	CcSEcCtD
Azacitidine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000505	0.00067	CcSEcCtD
Azacitidine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000505	0.000669	CcSEcCtD
Azacitidine—Pain—Pamidronate—osteoporosis	0.000503	0.000667	CcSEcCtD
Azacitidine—Constipation—Pamidronate—osteoporosis	0.000503	0.000667	CcSEcCtD
Azacitidine—Diarrhoea—Calcitriol—osteoporosis	0.000503	0.000667	CcSEcCtD
Azacitidine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000503	0.000667	CcSEcCtD
Azacitidine—Hypotension—Zoledronate—osteoporosis	0.000502	0.000666	CcSEcCtD
Azacitidine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000502	0.000666	CcSEcCtD
Azacitidine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000502	0.000666	CcSEcCtD
Azacitidine—Dizziness—Raloxifene—osteoporosis	0.000502	0.000666	CcSEcCtD
Azacitidine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000501	0.000664	CcSEcCtD
Azacitidine—Vomiting—Estropipate—osteoporosis	0.000498	0.000661	CcSEcCtD
Azacitidine—Dizziness—Ibandronate—osteoporosis	0.000497	0.000659	CcSEcCtD
Azacitidine—Rash—Estropipate—osteoporosis	0.000494	0.000655	CcSEcCtD
Azacitidine—Dermatitis—Estropipate—osteoporosis	0.000494	0.000654	CcSEcCtD
Azacitidine—Anorexia—Conjugated Estrogens—osteoporosis	0.000494	0.000654	CcSEcCtD
Azacitidine—Urticaria—Risedronate—osteoporosis	0.000492	0.000652	CcSEcCtD
Azacitidine—Back pain—Estradiol—osteoporosis	0.000491	0.000651	CcSEcCtD
Azacitidine—Headache—Estropipate—osteoporosis	0.000491	0.000651	CcSEcCtD
Azacitidine—Vomiting—Alendronate—osteoporosis	0.000491	0.000651	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00049	0.00065	CcSEcCtD
Azacitidine—Abdominal pain—Risedronate—osteoporosis	0.00049	0.000649	CcSEcCtD
Azacitidine—Body temperature increased—Risedronate—osteoporosis	0.00049	0.000649	CcSEcCtD
Azacitidine—Muscle spasms—Estradiol—osteoporosis	0.000488	0.000647	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—PSMA5—osteoporosis	0.000488	0.00225	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—PSMA2—osteoporosis	0.000488	0.00225	CbGpPWpGaD
Azacitidine—Rash—Alendronate—osteoporosis	0.000487	0.000645	CcSEcCtD
Azacitidine—Insomnia—Zoledronate—osteoporosis	0.000486	0.000645	CcSEcCtD
Azacitidine—Dermatitis—Alendronate—osteoporosis	0.000486	0.000645	CcSEcCtD
Azacitidine—Feeling abnormal—Pamidronate—osteoporosis	0.000485	0.000643	CcSEcCtD
Azacitidine—Hypotension—Conjugated Estrogens—osteoporosis	0.000484	0.000641	CcSEcCtD
Azacitidine—Headache—Alendronate—osteoporosis	0.000483	0.000641	CcSEcCtD
Azacitidine—Vomiting—Raloxifene—osteoporosis	0.000483	0.00064	CcSEcCtD
Azacitidine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000481	0.000638	CcSEcCtD
Azacitidine—Dyspnoea—Zoledronate—osteoporosis	0.000479	0.000636	CcSEcCtD
Azacitidine—Rash—Raloxifene—osteoporosis	0.000479	0.000635	CcSEcCtD
Azacitidine—Dermatitis—Raloxifene—osteoporosis	0.000478	0.000634	CcSEcCtD
Azacitidine—Vomiting—Ibandronate—osteoporosis	0.000478	0.000633	CcSEcCtD
Azacitidine—Headache—Raloxifene—osteoporosis	0.000476	0.00063	CcSEcCtD
Azacitidine—Rash—Ibandronate—osteoporosis	0.000474	0.000628	CcSEcCtD
Azacitidine—Dermatitis—Ibandronate—osteoporosis	0.000473	0.000628	CcSEcCtD
Azacitidine—Dyspepsia—Zoledronate—osteoporosis	0.000473	0.000628	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000472	0.000625	CcSEcCtD
Azacitidine—Ill-defined disorder—Estradiol—osteoporosis	0.000471	0.000625	CcSEcCtD
Azacitidine—Headache—Ibandronate—osteoporosis	0.000471	0.000624	CcSEcCtD
Azacitidine—Insomnia—Conjugated Estrogens—osteoporosis	0.000468	0.000621	CcSEcCtD
Azacitidine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000468	0.00062	CcSEcCtD
Azacitidine—Vomiting—Calcitriol—osteoporosis	0.000468	0.00062	CcSEcCtD
Azacitidine—Decreased appetite—Zoledronate—osteoporosis	0.000467	0.00062	CcSEcCtD
Azacitidine—Nausea—Estropipate—osteoporosis	0.000465	0.000617	CcSEcCtD
Azacitidine—Abdominal pain—Pamidronate—osteoporosis	0.000465	0.000617	CcSEcCtD
Azacitidine—Body temperature increased—Pamidronate—osteoporosis	0.000465	0.000617	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000464	0.000616	CcSEcCtD
Azacitidine—Rash—Calcitriol—osteoporosis	0.000464	0.000615	CcSEcCtD
Azacitidine—Fatigue—Zoledronate—osteoporosis	0.000464	0.000615	CcSEcCtD
Azacitidine—Dermatitis—Calcitriol—osteoporosis	0.000463	0.000614	CcSEcCtD
Azacitidine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000462	0.000612	CcSEcCtD
Azacitidine—Headache—Calcitriol—osteoporosis	0.000461	0.000611	CcSEcCtD
Azacitidine—Pain—Zoledronate—osteoporosis	0.00046	0.00061	CcSEcCtD
Azacitidine—Constipation—Zoledronate—osteoporosis	0.00046	0.00061	CcSEcCtD
Azacitidine—Nausea—Alendronate—osteoporosis	0.000458	0.000608	CcSEcCtD
Azacitidine—Malaise—Estradiol—osteoporosis	0.000458	0.000607	CcSEcCtD
Azacitidine—Hypersensitivity—Risedronate—osteoporosis	0.000456	0.000605	CcSEcCtD
Azacitidine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000456	0.000604	CcSEcCtD
Azacitidine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000456	0.000604	CcSEcCtD
Azacitidine—Syncope—Estradiol—osteoporosis	0.000455	0.000604	CcSEcCtD
Azacitidine—Nausea—Raloxifene—osteoporosis	0.000451	0.000598	CcSEcCtD
Azacitidine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00045	0.000597	CcSEcCtD
Azacitidine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000449	0.000596	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000447	0.000593	CcSEcCtD
Azacitidine—Fatigue—Conjugated Estrogens—osteoporosis	0.000446	0.000592	CcSEcCtD
Azacitidine—Nausea—Ibandronate—osteoporosis	0.000446	0.000592	CcSEcCtD
Azacitidine—Loss of consciousness—Estradiol—osteoporosis	0.000446	0.000592	CcSEcCtD
Azacitidine—Asthenia—Risedronate—osteoporosis	0.000444	0.000589	CcSEcCtD
Azacitidine—Feeling abnormal—Zoledronate—osteoporosis	0.000443	0.000588	CcSEcCtD
Azacitidine—Cough—Estradiol—osteoporosis	0.000443	0.000587	CcSEcCtD
Azacitidine—Constipation—Conjugated Estrogens—osteoporosis	0.000443	0.000587	CcSEcCtD
Azacitidine—Pain—Conjugated Estrogens—osteoporosis	0.000443	0.000587	CcSEcCtD
Azacitidine—Gastrointestinal pain—Zoledronate—osteoporosis	0.00044	0.000583	CcSEcCtD
Azacitidine—Hypertension—Estradiol—osteoporosis	0.000438	0.000581	CcSEcCtD
Azacitidine—Pruritus—Risedronate—osteoporosis	0.000438	0.000581	CcSEcCtD
Azacitidine—Nausea—Calcitriol—osteoporosis	0.000437	0.000579	CcSEcCtD
Azacitidine—CDA—Metabolism—CYP19A1—osteoporosis	0.000437	0.00202	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—ESR2—osteoporosis	0.000436	0.00201	CbGpPWpGaD
Azacitidine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000435	0.000576	CcSEcCtD
Azacitidine—Hypersensitivity—Pamidronate—osteoporosis	0.000434	0.000575	CcSEcCtD
Azacitidine—Chest pain—Estradiol—osteoporosis	0.000432	0.000573	CcSEcCtD
Azacitidine—Myalgia—Estradiol—osteoporosis	0.000432	0.000573	CcSEcCtD
Azacitidine—Arthralgia—Estradiol—osteoporosis	0.000432	0.000573	CcSEcCtD
Azacitidine—Anxiety—Estradiol—osteoporosis	0.000431	0.000571	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000429	0.000569	CcSEcCtD
Azacitidine—Urticaria—Zoledronate—osteoporosis	0.000427	0.000566	CcSEcCtD
Azacitidine—Discomfort—Estradiol—osteoporosis	0.000427	0.000566	CcSEcCtD
Azacitidine—Abdominal pain—Zoledronate—osteoporosis	0.000425	0.000564	CcSEcCtD
Azacitidine—Body temperature increased—Zoledronate—osteoporosis	0.000425	0.000564	CcSEcCtD
Azacitidine—Diarrhoea—Risedronate—osteoporosis	0.000424	0.000562	CcSEcCtD
Azacitidine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000423	0.000561	CcSEcCtD
Azacitidine—Asthenia—Pamidronate—osteoporosis	0.000422	0.00056	CcSEcCtD
Azacitidine—Dizziness—Ethinyl Estradiol—osteoporosis	0.00042	0.000557	CcSEcCtD
Azacitidine—Confusional state—Estradiol—osteoporosis	0.000418	0.000554	CcSEcCtD
Azacitidine—Pruritus—Pamidronate—osteoporosis	0.000416	0.000552	CcSEcCtD
Azacitidine—Anaphylactic shock—Estradiol—osteoporosis	0.000414	0.000549	CcSEcCtD
Azacitidine—Oedema—Estradiol—osteoporosis	0.000414	0.000549	CcSEcCtD
Azacitidine—Infection—Estradiol—osteoporosis	0.000412	0.000546	CcSEcCtD
Azacitidine—Urticaria—Conjugated Estrogens—osteoporosis	0.000411	0.000545	CcSEcCtD
Azacitidine—Dizziness—Risedronate—osteoporosis	0.00041	0.000543	CcSEcCtD
Azacitidine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000409	0.000543	CcSEcCtD
Azacitidine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000409	0.000543	CcSEcCtD
Azacitidine—Shock—Estradiol—osteoporosis	0.000408	0.000541	CcSEcCtD
Azacitidine—Nervous system disorder—Estradiol—osteoporosis	0.000406	0.000539	CcSEcCtD
Azacitidine—Tachycardia—Estradiol—osteoporosis	0.000404	0.000536	CcSEcCtD
Azacitidine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000404	0.000535	CcSEcCtD
Azacitidine—Diarrhoea—Pamidronate—osteoporosis	0.000403	0.000534	CcSEcCtD
Azacitidine—Skin disorder—Estradiol—osteoporosis	0.000403	0.000534	CcSEcCtD
Azacitidine—Hyperhidrosis—Estradiol—osteoporosis	0.000401	0.000531	CcSEcCtD
Azacitidine—Rash—Ethinyl Estradiol—osteoporosis	0.0004	0.000531	CcSEcCtD
Azacitidine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.0004	0.00053	CcSEcCtD
Azacitidine—Headache—Ethinyl Estradiol—osteoporosis	0.000398	0.000528	CcSEcCtD
Azacitidine—Hypersensitivity—Zoledronate—osteoporosis	0.000396	0.000525	CcSEcCtD
Azacitidine—Vomiting—Risedronate—osteoporosis	0.000394	0.000522	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—ESR1—osteoporosis	0.000391	0.00181	CbGpPWpGaD
Azacitidine—Rash—Risedronate—osteoporosis	0.00039	0.000518	CcSEcCtD
Azacitidine—Dermatitis—Risedronate—osteoporosis	0.00039	0.000517	CcSEcCtD
Azacitidine—Dizziness—Pamidronate—osteoporosis	0.000389	0.000516	CcSEcCtD
Azacitidine—Headache—Risedronate—osteoporosis	0.000388	0.000514	CcSEcCtD
Azacitidine—Asthenia—Zoledronate—osteoporosis	0.000386	0.000512	CcSEcCtD
Azacitidine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000381	0.000506	CcSEcCtD
Azacitidine—Pruritus—Zoledronate—osteoporosis	0.00038	0.000504	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000378	0.000501	CcSEcCtD
Azacitidine—Nausea—Ethinyl Estradiol—osteoporosis	0.000377	0.0005	CcSEcCtD
Azacitidine—Insomnia—Estradiol—osteoporosis	0.000375	0.000497	CcSEcCtD
Azacitidine—Vomiting—Pamidronate—osteoporosis	0.000374	0.000496	CcSEcCtD
Azacitidine—Asthenia—Conjugated Estrogens—osteoporosis	0.000371	0.000493	CcSEcCtD
Azacitidine—Rash—Pamidronate—osteoporosis	0.000371	0.000492	CcSEcCtD
Azacitidine—Dermatitis—Pamidronate—osteoporosis	0.000371	0.000492	CcSEcCtD
Azacitidine—Dyspnoea—Estradiol—osteoporosis	0.000369	0.00049	CcSEcCtD
Azacitidine—Headache—Pamidronate—osteoporosis	0.000369	0.000489	CcSEcCtD
Azacitidine—Diarrhoea—Zoledronate—osteoporosis	0.000368	0.000488	CcSEcCtD
Azacitidine—Nausea—Risedronate—osteoporosis	0.000368	0.000488	CcSEcCtD
Azacitidine—Pruritus—Conjugated Estrogens—osteoporosis	0.000366	0.000486	CcSEcCtD
Azacitidine—Dyspepsia—Estradiol—osteoporosis	0.000365	0.000484	CcSEcCtD
Azacitidine—Decreased appetite—Estradiol—osteoporosis	0.00036	0.000478	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000358	0.000474	CcSEcCtD
Azacitidine—Fatigue—Estradiol—osteoporosis	0.000357	0.000474	CcSEcCtD
Azacitidine—CDA—Metabolism—ADCY5—osteoporosis	0.000357	0.00165	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GPX1—osteoporosis	0.000356	0.00164	CbGpPWpGaD
Azacitidine—Dizziness—Zoledronate—osteoporosis	0.000356	0.000471	CcSEcCtD
Azacitidine—Constipation—Estradiol—osteoporosis	0.000354	0.00047	CcSEcCtD
Azacitidine—Pain—Estradiol—osteoporosis	0.000354	0.00047	CcSEcCtD
Azacitidine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000354	0.00047	CcSEcCtD
Azacitidine—Nausea—Pamidronate—osteoporosis	0.00035	0.000464	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—VDR—osteoporosis	0.000346	0.0016	CbGpPWpGaD
Azacitidine—Dizziness—Conjugated Estrogens—osteoporosis	0.000342	0.000454	CcSEcCtD
Azacitidine—Vomiting—Zoledronate—osteoporosis	0.000342	0.000453	CcSEcCtD
Azacitidine—Feeling abnormal—Estradiol—osteoporosis	0.000341	0.000453	CcSEcCtD
Azacitidine—Rash—Zoledronate—osteoporosis	0.000339	0.00045	CcSEcCtD
Azacitidine—Gastrointestinal pain—Estradiol—osteoporosis	0.000339	0.000449	CcSEcCtD
Azacitidine—Dermatitis—Zoledronate—osteoporosis	0.000339	0.000449	CcSEcCtD
Azacitidine—Headache—Zoledronate—osteoporosis	0.000337	0.000447	CcSEcCtD
Azacitidine—Vomiting—Conjugated Estrogens—osteoporosis	0.000329	0.000436	CcSEcCtD
Azacitidine—Urticaria—Estradiol—osteoporosis	0.000329	0.000436	CcSEcCtD
Azacitidine—CDA—Metabolism—MTHFR—osteoporosis	0.000328	0.00152	CbGpPWpGaD
Azacitidine—Abdominal pain—Estradiol—osteoporosis	0.000328	0.000434	CcSEcCtD
Azacitidine—Body temperature increased—Estradiol—osteoporosis	0.000328	0.000434	CcSEcCtD
Azacitidine—Rash—Conjugated Estrogens—osteoporosis	0.000326	0.000433	CcSEcCtD
Azacitidine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000326	0.000432	CcSEcCtD
Azacitidine—Headache—Conjugated Estrogens—osteoporosis	0.000324	0.00043	CcSEcCtD
Azacitidine—Nausea—Zoledronate—osteoporosis	0.000319	0.000423	CcSEcCtD
Azacitidine—Nausea—Conjugated Estrogens—osteoporosis	0.000308	0.000408	CcSEcCtD
Azacitidine—Hypersensitivity—Estradiol—osteoporosis	0.000305	0.000405	CcSEcCtD
Azacitidine—Asthenia—Estradiol—osteoporosis	0.000297	0.000394	CcSEcCtD
Azacitidine—Pruritus—Estradiol—osteoporosis	0.000293	0.000389	CcSEcCtD
Azacitidine—Diarrhoea—Estradiol—osteoporosis	0.000284	0.000376	CcSEcCtD
Azacitidine—Dizziness—Estradiol—osteoporosis	0.000274	0.000363	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—ESR1—osteoporosis	0.000264	0.00122	CbGpPWpGaD
Azacitidine—Vomiting—Estradiol—osteoporosis	0.000263	0.000349	CcSEcCtD
Azacitidine—CDA—Metabolism—POMC—osteoporosis	0.000262	0.00121	CbGpPWpGaD
Azacitidine—Rash—Estradiol—osteoporosis	0.000261	0.000346	CcSEcCtD
Azacitidine—Dermatitis—Estradiol—osteoporosis	0.000261	0.000346	CcSEcCtD
Azacitidine—Headache—Estradiol—osteoporosis	0.00026	0.000344	CcSEcCtD
Azacitidine—Nausea—Estradiol—osteoporosis	0.000246	0.000326	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—MYC—osteoporosis	0.000204	0.00094	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—MYC—osteoporosis	0.000137	0.000635	CbGpPWpGaD
